2014
GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare
Stryker edges The Street despite plunging Q3 profits
Getinge trims sales forecast as Q3 falls short
St. Jude Medical CEO: CardioMEMS the ‘single most important new growth driver’
Medical products push Baxter profit above estimate
St. Jude Medical’s adjusted profit rises
J&J sales top forecast, helped by hepatitis drug
AngioDynamics revises results, ups guidance
Biomet’s Q1 profits plunge despite sales increases
Biomet today reported a 77% profit slide for its fiscal 1st quarter, despite posting sales gains across its all but 1 line of orthopedic implants.